Decheng Capital’s Cue Health Inc. Common Stock HLTH Stock Holding History

Decheng Capital’s Portfolio HLTH Stock Details HLTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,980,909	Closed	-$1.7M	–	27
2024 Q1	$1.7M	Hold	8,980,909	–	–	0.23%	18
2023 Q4	$1.46M	Buy	+8,980,909	New	+$2.98M	0.41%	20

Other funds holding HLTH

Tarsadia Capital New York $5.64M AUM 15.7% 1-Year Est. Return

Oakmont Corp Los Angeles, California $526M AUM 7.52% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Old Point Trust & Financial Services N A Newport News, Virginia $311M AUM 24.14% 1-Year Est. Return

Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return

Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

Decheng Capital's HLTH Position: Q2 2024 in Review

Decheng Capital sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2024, closing a stake of 8,980,909 shares — an estimated $1.7M sold.

Decheng Capital first reported a position in HLTH in Q4 2023 and held it in 2 quarters. The position peaked at $1.7M in Q1 2024. 9 funds tracked by Wall St. Rank hold HLTH as of Q2 2024.

Decheng Capital reported no remaining Cue Health Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Decheng Capital sold 8,980,909 Cue Health Inc. Common Stock shares in Q2 2024, an estimated $1.7M.
Decheng Capital first reported a position in Cue Health Inc. Common Stock in Q4 2023 and held it in 2 quarters.
Decheng Capital's Cue Health Inc. Common Stock position peaked at $1.7M in Q1 2024.
9 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2024.

Based on Decheng Capital's 13F filing for Q2 2024, filed 14 Aug 2024.